We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DRAGON AIMS TO MARKET GENERIC EPO BIOLOGIC IN EUROPEAN MARKET
DRAGON AIMS TO MARKET GENERIC EPO BIOLOGIC IN EUROPEAN MARKET
July 20, 2004
As the generic drug industry urges the FDA and Congress to develop an approval pathway for generic biologics, some firms already are marketing the products.